StockPriceToday
Intel Corp (INTC)
About Intel Corp
Intel Corporation designs, manufactures, and sells computer processors and related technologies for computing and communications industries worldwide. As a foundational semiconductor company, INTC stock price often reflects broader technology industry trends and concerns about competitive positioning in key markets.
Intel's processors power millions of personal computers, servers, and data center equipment globally, making it one of the world's largest semiconductor companies by revenue. The company's x86 architecture has been the dominant instruction set for personal computers and servers for decades.
The company faces increasing competition from Advanced Micro Devices in both consumer and data center markets, as well as from companies developing ARM-based processors for various applications. Intel's manufacturing capabilities and process technology development remain critical factors influencing INTC stock price performance.
Intel's strategic initiatives include expanding into artificial intelligence, autonomous vehicles, and edge computing applications. The company's significant investments in new manufacturing facilities and process technology development demonstrate its commitment to maintaining technological leadership and addressing growing semiconductor demand across multiple industries.
INTC Stock 12 Month Chart
Latest News for INTC
Intel's foundry business may turn a profit in the near future.
Intel is funding a costly foundry turnaround, and Marvell Technology's faster growth depends on a small group of data center customers.
Intel has the government, Nvidia, and SoftBank betting on its comeback, but the real question is whether it can turn that support into the customers and profits needed to justify the hype.
Other Popular Stocks
Kirkland's Inc. (KIRK) is a specialty retailer of home d�cor and furniture operating stores primarily in small to mid-size markets across the United States.
CommScope Holding Company Inc. (COMM) is a global leader in infrastructure solutions for communications networks, serving telecommunications and enterprise customers worldwide.
MacroGenics Inc. (MGNX) is a biotechnology company developing innovative antibody-based therapeutics for cancer treatment using proprietary antibody engineering and immune system targeting approaches.